MedTrace Logo

Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP

NCT02844036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2017-10-23

No results posted yet for this study

Summary

Currently, the standard treatment for proximal thromboses lesions responsible for post-embolic pulmonary hypertension, is the surgical thromboendarterectomy. When the ravages are judged too distal or the patient is judged inoperable for a curative surgical gesture, there is no evidence of any therapeutic option, exept for K anti-vitamins for recurrent embolism. Prognosis is then pejorative with a 60% mortality at 5 years.

This study propose an alternative treatment for these patients in therapeutic "dead end". This is about applying arterial thrombosis technique to the pulmonary circulation.

Conditions

  • Pulmonary Hypertension

Interventions

PROCEDURE

Percutaneous angioplasty

PROCEDURE

Balloon angioplasty

PROCEDURE

Right heart catheterization

PROCEDURE

Echocardiography

OTHER

A six-minute walking test

PROCEDURE

Functional respiratory investigations

PROCEDURE

Pulmonary tomography or pulmonary angiography

OTHER

Biological parameters

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Hélène Bouvaist, Doctor · Grenoble Hospital University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844036 on ClinicalTrials.gov